JP2017509608A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017509608A5 JP2017509608A5 JP2016552980A JP2016552980A JP2017509608A5 JP 2017509608 A5 JP2017509608 A5 JP 2017509608A5 JP 2016552980 A JP2016552980 A JP 2016552980A JP 2016552980 A JP2016552980 A JP 2016552980A JP 2017509608 A5 JP2017509608 A5 JP 2017509608A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- butyl
- iso
- propyl
- butoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 2-ethylphenyl Chemical group 0.000 claims description 310
- 238000000034 method Methods 0.000 claims description 63
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 14
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 125000005843 halogen group Chemical group 0.000 claims description 6
- FFUAGWLWBBFQJT-UHFFFAOYSA-N hexamethyldisilazane Chemical group C[Si](C)(C)N[Si](C)(C)C FFUAGWLWBBFQJT-UHFFFAOYSA-N 0.000 claims description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- WFROSYVMUUJSPL-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-3-hydroxypyridin-2-one Chemical compound O=C1C(O)=CC=CN1CC1=CC=C(Cl)C=C1 WFROSYVMUUJSPL-UHFFFAOYSA-N 0.000 claims description 4
- YYOJBSBLTSAPCS-UHFFFAOYSA-N 1-benzyl-3-hydroxypyridin-2-one Chemical compound O=C1C(O)=CC=CN1CC1=CC=CC=C1 YYOJBSBLTSAPCS-UHFFFAOYSA-N 0.000 claims description 4
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 4
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 4
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical compound OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 claims description 4
- UPJZLOCUUOIMNC-UHFFFAOYSA-N tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate Chemical compound C1CN(C(=O)OC(C)(C)C)CCN1CC1=C(O)C(=O)N(CC=2C=CC(Cl)=CC=2)C=C1 UPJZLOCUUOIMNC-UHFFFAOYSA-N 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- 125000004201 2,4-dichlorophenyl group Chemical group [H]C1=C([H])C(*)=C(Cl)C([H])=C1Cl 0.000 claims description 2
- 125000004215 2,4-difluorophenyl group Chemical group [H]C1=C([H])C(*)=C(F)C([H])=C1F 0.000 claims description 2
- 125000006276 2-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000004182 2-chlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000004198 2-fluorophenyl group Chemical group [H]C1=C([H])C(F)=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000006304 2-iodophenyl group Chemical group [H]C1=C([H])C(I)=C(*)C([H])=C1[H] 0.000 claims description 2
- 125000004204 2-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C(OC([H])([H])[H])C([H])=C1[H] 0.000 claims description 2
- 125000004362 3,4,5-trichlorophenyl group Chemical group [H]C1=C(Cl)C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 2
- 125000004361 3,4,5-trifluorophenyl group Chemical group [H]C1=C(F)C(F)=C(F)C([H])=C1* 0.000 claims description 2
- 125000004189 3,4-dichlorophenyl group Chemical group [H]C1=C([H])C(Cl)=C(Cl)C([H])=C1* 0.000 claims description 2
- 125000004211 3,5-difluorophenyl group Chemical group [H]C1=C(F)C([H])=C(*)C([H])=C1F 0.000 claims description 2
- 125000006275 3-bromophenyl group Chemical group [H]C1=C([H])C(Br)=C([H])C(*)=C1[H] 0.000 claims description 2
- 125000004179 3-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(Cl)=C1[H] 0.000 claims description 2
- 125000004180 3-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(F)=C1[H] 0.000 claims description 2
- 125000006305 3-iodophenyl group Chemical group [H]C1=C([H])C(I)=C([H])C(*)=C1[H] 0.000 claims description 2
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 claims description 2
- 125000004800 4-bromophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Br 0.000 claims description 2
- 125000004860 4-ethylphenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 2
- 125000006306 4-iodophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1I 0.000 claims description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 150000002367 halogens Chemical class 0.000 claims description 2
- 125000004491 isohexyl group Chemical group C(CCC(C)C)* 0.000 claims description 2
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 2
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 claims description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 claims description 2
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 claims description 2
- CWXPZXBSDSIRCS-UHFFFAOYSA-N tert-butyl piperazine-1-carboxylate Chemical compound CC(C)(C)OC(=O)N1CCNCC1 CWXPZXBSDSIRCS-UHFFFAOYSA-N 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 125000002346 iodo group Chemical group I* 0.000 claims 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 0 *Cc1ccc(CI2*C2)cc1 Chemical compound *Cc1ccc(CI2*C2)cc1 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461941540P | 2014-02-19 | 2014-02-19 | |
| US61/941,540 | 2014-02-19 | ||
| PCT/US2015/016243 WO2015126860A1 (en) | 2014-02-19 | 2015-02-18 | Process for preparing n-benzyl-3-hydroxy-4-substituted-pyridin-2-(1h)-ones |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017509608A JP2017509608A (ja) | 2017-04-06 |
| JP2017509608A5 true JP2017509608A5 (enExample) | 2018-03-22 |
| JP6549140B2 JP6549140B2 (ja) | 2019-07-24 |
Family
ID=53797499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016552980A Expired - Fee Related JP6549140B2 (ja) | 2014-02-19 | 2015-02-18 | Ｎ−ベンジル−３−ヒドロキシ−４−置換ピリジン−２−（１ｈ）−オン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9388135B2 (enExample) |
| EP (1) | EP3107542B1 (enExample) |
| JP (1) | JP6549140B2 (enExample) |
| CN (1) | CN106232120B (enExample) |
| ES (1) | ES2739625T3 (enExample) |
| SG (1) | SG11201606862VA (enExample) |
| WO (1) | WO2015126860A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
| PL2451279T3 (pl) | 2009-07-06 | 2019-09-30 | Aerpio Therapeutics, Inc. | Pochodne benzosulfonamidowe, ich kompozycje i ich zastosowanie w zapobieganiu przerzutom komórek nowotworowych |
| RS54010B1 (sr) | 2009-11-06 | 2015-10-30 | Aerpio Therapeutics Inc. | Inhibitori prolil hidroksilaze |
| AU2012323856B2 (en) | 2011-10-13 | 2017-05-25 | EyePoint Pharmaceuticals, Inc. | Methods for treating Vascular Leak Syndrome and cancer |
| EP4101297A1 (en) | 2013-03-15 | 2022-12-14 | Aerpio Pharmaceuticals, Inc. | Compositions, formulations and methods for treating ocular diseases |
| US20150050277A1 (en) | 2013-03-15 | 2015-02-19 | Aerpio Therapeutics Inc. | Compositions and methods for treating ocular diseases |
| WO2016022813A1 (en) | 2014-08-07 | 2016-02-11 | Aerpio Therapeutics, Inc. | Combination of immunotherapies with activators of tie-2 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4508898A (en) * | 1980-09-16 | 1985-04-02 | Ogilvie Kelvin K | Antiviral triazine compounds |
| US7226755B1 (en) | 2002-09-25 | 2007-06-05 | The Procter & Gamble Company | HPTPbeta as a target in treatment of angiogenesis mediated disorders |
| US7507568B2 (en) | 2002-09-25 | 2009-03-24 | The Proctor & Gamble Company | Three dimensional coordinates of HPTPbeta |
| US6930117B2 (en) | 2002-11-09 | 2005-08-16 | The Procter & Gamble Company | N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones |
| US6946479B2 (en) | 2002-11-09 | 2005-09-20 | The Procter & Gamble Company | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| EP3252079B8 (en) | 2006-04-07 | 2020-09-09 | Aerpio Therapeutics LLC | Antibodies that bind human protein tyrosine phosphatase beta (hptp-beta) and uses thereof |
| AR061570A1 (es) * | 2006-06-23 | 2008-09-03 | Smithkline Beecham Corp | Compuesto de glicina sustituido en el n heteroaromatico composicion farmaceutica que lo comprende, su uso para preparar un medicamento, procedimientos para preparar dicha composicion farmaceutica y para preparar el compuesto |
| ATE485264T1 (de) | 2006-06-26 | 2010-11-15 | Warner Chilcott Co Llc | Prolylhydroxylase-hemmer und verfahren zu ihrer anwendung |
| US7795444B2 (en) | 2006-06-27 | 2010-09-14 | Warner Chilcott Company | Human protein tyrosine phosphatase inhibitors and methods of use |
| US7622593B2 (en) | 2006-06-27 | 2009-11-24 | The Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
| US7589212B2 (en) | 2006-06-27 | 2009-09-15 | Procter & Gamble Company | Human protein tyrosine phosphatase inhibitors and methods of use |
| US8846685B2 (en) | 2006-06-27 | 2014-09-30 | Aerpio Therapeutics Inc. | Human protein tyrosine phosphatase inhibitors and methods of use |
| US20130023542A1 (en) | 2006-06-27 | 2013-01-24 | Aerpio Therapeutics Inc. | Human protein tyrosine phosphatase inhibitors and methods of use |
| US9096555B2 (en) | 2009-01-12 | 2015-08-04 | Aerpio Therapeutics, Inc. | Methods for treating vascular leak syndrome |
| CN109771421A (zh) | 2009-01-12 | 2019-05-21 | 爱尔皮奥治疗有限公司 | 治疗血管渗漏综合征的方法 |
| AU2011312203C1 (en) | 2009-01-12 | 2016-09-08 | EyePoint Pharmaceuticals, Inc. | Compositions and methods for treating ocular edema, neovascularization and related diseases |
| US8883832B2 (en) | 2009-07-06 | 2014-11-11 | Aerpio Therapeutics Inc. | Compounds, compositions, and methods for preventing metastasis of cancer cells |
| PL2451279T3 (pl) | 2009-07-06 | 2019-09-30 | Aerpio Therapeutics, Inc. | Pochodne benzosulfonamidowe, ich kompozycje i ich zastosowanie w zapobieganiu przerzutom komórek nowotworowych |
| RS54010B1 (sr) | 2009-11-06 | 2015-10-30 | Aerpio Therapeutics Inc. | Inhibitori prolil hidroksilaze |
| AU2012323856B2 (en) | 2011-10-13 | 2017-05-25 | EyePoint Pharmaceuticals, Inc. | Methods for treating Vascular Leak Syndrome and cancer |
| HK1201196A1 (en) | 2011-10-13 | 2015-08-28 | Aerpio Therapeutics, Inc. | Treatment of ocular disease |
| EP4101297A1 (en) | 2013-03-15 | 2022-12-14 | Aerpio Pharmaceuticals, Inc. | Compositions, formulations and methods for treating ocular diseases |
| US20150050277A1 (en) | 2013-03-15 | 2015-02-19 | Aerpio Therapeutics Inc. | Compositions and methods for treating ocular diseases |
-
2015
- 2015-02-18 CN CN201580020246.8A patent/CN106232120B/zh not_active Expired - Fee Related
- 2015-02-18 EP EP15751652.7A patent/EP3107542B1/en active Active
- 2015-02-18 US US14/624,625 patent/US9388135B2/en not_active Expired - Fee Related
- 2015-02-18 WO PCT/US2015/016243 patent/WO2015126860A1/en not_active Ceased
- 2015-02-18 JP JP2016552980A patent/JP6549140B2/ja not_active Expired - Fee Related
- 2015-02-18 SG SG11201606862VA patent/SG11201606862VA/en unknown
- 2015-02-18 ES ES15751652T patent/ES2739625T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017509608A5 (enExample) | ||
| RU2012138259A (ru) | Способ получения ривароксабана | |
| TWI570098B (zh) | 苯乙醯胺化合物的製造方法 | |
| JP2013512988A5 (enExample) | ||
| RU2014117188A (ru) | Способ получения производных 4,4-дифтор-3,4-дигидроизохинолина | |
| RU2009110413A (ru) | Способ получения производных 3-дигалогенметил-пиразол-4-карбоновой кислоты | |
| JP2013525264A5 (enExample) | ||
| JP2012526842A5 (enExample) | ||
| JP2010510976A5 (enExample) | ||
| JP6549140B2 (ja) | Ｎ−ベンジル−３−ヒドロキシ−４−置換ピリジン−２−（１ｈ）−オン | |
| JP2018528182A5 (enExample) | ||
| JP4178151B2 (ja) | 光学活性なα−ヒドロキシホスホン酸及びその誘導体の製造方法、光学活性アルミニウム（サラレン）錯体及びその製造方法、並びにサラレン配位子の製造方法 | |
| JPWO2021220648A5 (enExample) | ||
| RU2014129937A (ru) | Способы и промежуточные соединения для получения фармацевтических агентов | |
| CA2418040A1 (en) | Process for the preparation of substituted phenylacetonitriles | |
| CA2368276A1 (en) | Process for preparing alkoxy or arylmethoxy aroxyethanes | |
| CY1112279T1 (el) | Εποξειδικη ενωση και μεθοδος για την παρασκευη της | |
| RU2008145775A (ru) | Синтез и способы применения производных пироглутаминовой кислоты | |
| GB201209840D0 (en) | Novel process and catalyst | |
| JP2012017285A5 (enExample) | ||
| ES2615729T3 (es) | Proceso para preparar 3-haloalquilpirazoles | |
| JP2011500928A5 (enExample) | ||
| RU2013110311A (ru) | Синтез соединений тиазолидиндиона | |
| ES422472A1 (es) | Procedimiento para preparar 2- (fenoxialquiltio) imidazo- les. | |
| RU2012121591A (ru) | Способ получения органических соединений |